SAM
Sectoral Asset Management’s Royalty Pharma RPRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $334K | Hold |
9,280
| – | – | 0.22% | 78 |
|
2025
Q1 | $289K | Buy |
9,280
+2,080
| +29% | +$64.8K | 0.22% | 64 |
|
2024
Q4 | $184K | Sell |
7,200
-9,230
| -56% | -$235K | 0.12% | 79 |
|
2024
Q3 | $465K | Sell |
16,430
-220
| -1% | -$6.22K | 0.27% | 66 |
|
2024
Q2 | $439K | Sell |
16,650
-2,770
| -14% | -$73K | 0.18% | 70 |
|
2024
Q1 | $590K | Sell |
19,420
-1,150
| -6% | -$34.9K | 0.23% | 63 |
|
2023
Q4 | $578K | Buy |
20,570
+2,620
| +15% | +$73.6K | 0.25% | 72 |
|
2023
Q3 | $487K | Buy |
17,950
+2,588
| +17% | +$70.2K | 0.09% | 107 |
|
2023
Q2 | $472K | Buy |
15,362
+2,922
| +23% | +$89.8K | 0.08% | 108 |
|
2023
Q1 | $448K | Hold |
12,440
| – | – | 0.09% | 104 |
|
2022
Q4 | $492K | Buy |
12,440
+300
| +2% | +$11.9K | 0.1% | 103 |
|
2022
Q3 | $488K | Sell |
12,140
-1,700
| -12% | -$68.3K | 0.1% | 88 |
|
2022
Q2 | $582K | Buy |
+13,840
| New | +$582K | 0.12% | 91 |
|